Key result
AT(1) receptor blockade with L-158,809 significantly attenuated hypoxia-induced increases in pulmonary arterial pressure (P<0.0001) and pulmonary vascular resistance (P<0.02) in newborn piglets.
Why the study?
Does AT1 receptor blockade with L-158,809 reduce hypoxia-induced pulmonary hypertension in newborn piglets?
RCT (n=18)
randomly assigned
Does AT1 receptor blockade with L-158,809 reduce hypoxia-induced pulmonary hypertension in newborn piglets?
p-value: p=<0.0001
AT1 receptor blockade with L-158,809 partially attenuates hypoxia-induced pulmonary hypertension in newborn piglets, potentially through interactions with the nitrergic system.
AT1 blockade attenuates hypoxia-induced PH in piglets; hypothesis-generating for neonatal use and leaves clinical translation open.
The objective of this study was to observe possible interactions between the renin-angiotensin and nitrergic systems in chronic hypoxia-induced pulmonary hypertension in newborn piglets. Thirteen chronically instrumented newborn piglets (6.3 ± 0.9 days; 2369 ± 491 g) were randomly assigned to receive saline (placebo, P) or the AT(1) receptor (AT(1)-R) blocker L-158,809 (L) during 6 days of hypoxia (FiO(2) = 0.12). During hypoxia, pulmonary arterial pressure (Ppa; P < 0.0001), pulmonary vascular resistance (PVR; P < 0.02) and the pulmonary to systemic vascular resistance ratio (PVR/SVR; P < 0.05) were significantly attenuated in the L (N = 7) group compared to the P group (N = 6). Western blot analysis of lung proteins showed a significant decrease of endothelial NOS (eNOS) in both P and L animals, and of AT(1)-R in P animals during hypoxia compared to normoxic animals (C group, N = 5; P < 0.01 for all groups). AT(1)-R tended to decrease in L animals. Inducible NOS (iNOS) did not differ among P, L, and C animals and iNOS immunohistochemical staining in macrophages was significantly more intense in L than in P animals (P < 0.01). The vascular endothelium showed moderate or strong eNOS and AT(1)-R staining. Macrophages and pneumocytes showed moderate or strong iNOS and AT(1)-R staining, but C animals showed weak iNOS and AT(1)-R staining. Macrophages of L and P animals showed moderate and weak AT(2)-R staining, respectively, but the endothelium of all groups only showed weak staining. In conclusion, pulmonary hypertension induced by chronic hypoxia in newborn piglets is partially attenuated by AT(1)-R blockade. We suggest that AT(1)-R blockade might act through AT(2)-R and/or Mas receptors and the nitrergic system in the lungs of hypoxemic newborn piglets.
No takes yet. Share an insight, caveat, or question.
Camelo et al. (2012) conducted an RCT in chronic hypoxia-induced pulmonary hypertension (n=18). AT(1) receptor blocker L-158,809 vs. saline (placebo) was evaluated on pulmonary arterial pressure (Ppa) (p=<0.0001). AT(1) receptor blockade with L-158,809 significantly attenuated hypoxia-induced increases in pulmonary arterial pressure (P<0.0001) and pulmonary vascular resistance (P<0.02) in newborn piglets.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: